Skip to content

Solomon Moshkevich, President, Clinicaldiagnostics at Natera, sold NTRA on Sep 1, 2026

Data as of Oct 16

▼ SELL$193K600 shares at $321.91Solomon Moshkevich President, ClinicaldiagnosticsNTRA Natera, Inc.
Watch NTRA
Traded
Sep 1, 2026
Disclosed
Sep 3, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Solomon Moshkevich, President, Clinicaldiagnostics at Natera, sold NTRA on Sep 1, 2026TRADEDDISCLOSED
NTRASimilar stocks (XLV — its sector index fund), rebased to NTRA's price on the disclosure day
NTRA since disclosure
+20.1%
after the sale
Similar stocks (XLV) since disclosure
+2.0%
XLV — its sector index fund

Change in closing price from Sep 3, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLSolomon Moshkevich President, ClinicaldiagnosticsNTRA Natera, Inc.$5Mdisclosed Sep 3 · filed 1 day after the trade
  2. ▼ SELLSolomon Moshkevich President, ClinicaldiagnosticsNTRA Natera, Inc.$320Kdisclosed Sep 3 · filed 2 days after the trade
  3. ▼ SELLSolomon Moshkevich President, ClinicaldiagnosticsNTRA Natera, Inc.$449Kdisclosed Sep 3 · filed 2 days after the trade

See every trade on NTRA →